30 July 2021 | Friday | News
Image Source : retainup.co
CliniRx has achieved accreditation as a CRO partner for Medidata Rave EDC, joining Medidata's industry-leading partner program to further advance its technical and operational performance. CliniRx can now offer the full suite of Rave EDC and clinical data management (CDM) services to sponsors. Part of the Medidata Clinical CloudTM, Rave EDC (electronic data capture) is an advanced and robust system for capturing, managing, and reporting clinical research data.
CliniRx is a full-service global CRO (contract research organization), conducting multinational clinical trials for pharma, biotech, and medical devices companies. CliniRx's staff have undergone rigorous accreditation processes by Medidata and are fully trained to take on a variety of complex clinical data management projects. Through this partnership, CliniRx has filled the gaps on the supply side of the market with Medidata's industry-leading solution.
"Attaining the Medidata Rave EDC accreditation demonstrates our dedication to bringing high-end solutions with optimal efficiencies to our customers for clinical trials across all study phases and therapeutic areas," said Shiv Issar, Head of CliniRx. "We can guide sponsors through every aspect of the database build to ensure best data management practices are employed. We are confident that in aligning with industry leaders like Medidata, we can deliver quality data that our customers trust. We view this accreditation and partnership milestone as a continuing investment in our technologies that help us to bring the highest level of value to our customers," Mr. Issar added.
"CliniRx's dedication and expertise enabled them to achieve Medidata Rave EDC accreditation within a short timeline," said Edwin Ng, Senior Vice President, General Manager, APAC, at Medidata. "Their customers can now benefit from Medidata's scalable unified platform, which adapts as needed across the global ecosystem. We are excited to evolve our partnership with the CliniRx team as they further enhance the value they bring to their customers."
Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.